ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,886Medicare Part D Prescriptions Filled, Including Refills

Rank: 234 out of 780

$497K Total Retail Price of All Prescriptions

Rank: 298 out of 780

498 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 10,550 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 452 329 S3 1 1
LEVOTHYROXINE SODIUM 448 442 2 5
FUROSEMIDE 360 339 3 7
SIMVASTATIN 359 343 4 2
METFORMIN HCL 316 276 5 8
TRAMADOL HCL 314 265 6 15
LISINOPRIL 279 251 7 6
AMLODIPINE BESYLATE 270 257 8 4
OMEPRAZOLE 268 233 9 3
WARFARIN SODIUM 258 225 10 24
DONEPEZIL HCL 219 217 11 31
GABAPENTIN 191 172 12 13
ZOLPIDEM TARTRATE 190 168 13 17
HYDROCHLOROTHIAZIDE 176 155 14 10
ATENOLOL 172 150 15 21
MIRTAZAPINE 166 148 16 58
POTASSIUM CHLORIDE 157 153 17 11
METOPROLOL TARTRATE 155 131 18 19
QUETIAPINE FUMARATE 143 134 19 81
CLONIDINE HCL 141 110 20 28
ENALAPRIL MALEATE 128 128 21 64
CARVEDILOL 107 94 22 14
RISPERIDONE 107 79 22 98
TAMSULOSIN HCL 106 104 24 36
PREDNISONE 100 77 25 40
ATORVASTATIN CALCIUM 95 84 26 12
ISOSORBIDE MONONITRATE ER 92 83 27 60
PRAVASTATIN SODIUM 92 86 27 9
CIPROFLOXACIN HCL 92 77 27 49
ALLOPURINOL 92 80 27 29
METOPROLOL SUCCINATE 83 83 31 20
LOSARTAN POTASSIUM 81 81 32 18
AZITHROMYCIN 81 72 32 38
NAMENDA 80 80 34 46
FLUOXETINE HCL 79 79 35 65
OXAPROZIN 78 73 36 390
LOVASTATIN 73 49 37 47
DICLOFENAC SODIUM 70 70 38 137
AMOX TR-POTASSIUM CLAVULANATE 68 53 39 135
PROMETHAZINE HCL 67 34 R 40 66
LANTUS SOLOSTAR 66 64 41 121
LOSARTAN-HYDROCHLOROTHIAZIDE 66 54 41 33
LEVOFLOXACIN 66 63 41 76
TRIAMTERENE-HCTZ 66 62 41 37
CITALOPRAM HBR 65 60 45 23
NEXIUM 64 51 46 22
NOVOLIN R 62 62 47 212
SERTRALINE HCL 61 47 48 27
LITHIUM CARBONATE 60 47 49 302
BUSPIRONE HCL 57 57 50 125
MELOXICAM 56 48 51 16
NITROFURANTOIN MONO-MACRO 55 52 52 247
DIGOXIN 54 54 53 56
CYMBALTA 54 52 53 51
DIVALPROEX SODIUM ER 54 43 53 216
SEROQUEL 52 45 56 172
KLOR-CON 10 52 45 56 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.